Shanghai Junshi Biosciences Co., Ltd. (1877.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap19.27B
Enterprise Value20.79B
P/E Ratio-73.54
PEG Ratio-0.84
Price/Sales Ratio7.36
Price/Book Ratio5.42
Enterprise/Revenue8.39
Enterprise/EBITDA-86.93

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.13
Operating Margin-0.16
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.07

Income Statement

Revenue2.43B
Revenue/Share3.13
Gross Profit1.97B
EBITDA-599.38M
Net Income-851.76M
Diluted EPS-0.84

Balance Sheet

Total Cash4.37B
Total Cash/Share4.26
Total Debt6.82B
Total Debt/Equity1.17
Current Ratio2.05
Book Value Per Share5.88

Price History

52-Week Change-38.27
52-Week High30.8
52-Week Low14.8
Moving Average 50 Days17.13
Moving Average 200 Days20

Statistics

Average Volume2.2M
Shares Outstanding1.41B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.12
Last Split FactorN/A
Last Split DateN/A
AD